Patents by Inventor XIANG JI

XIANG JI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240158343
    Abstract: There are provided isotope-enriched compounds of Formula (I) and pharmaceutically acceptable salts or esters thereof, as well as pharmaceutical compositions thereof and methods of use thereof for prevention and treatment of amyloid-? related diseases, such as Alzheimer's disease.
    Type: Application
    Filed: January 19, 2024
    Publication date: May 16, 2024
    Inventors: Jiasheng LU, Jiamin GU, Xinyong LV, Guowei SONG, Dongdong WU, Daiqiang HU, Jun GU, Gang CHEN, Xiang JI, Xiuchun ZHANG, Jinchao AI, Xianqi KONG
  • Patent number: 11970490
    Abstract: There are provided isotope-enriched compounds containing stable heavy isotope-enriched amide functional groups for modulating the pharmacokinetic profile, metabolic profile, and/or delivery efficiency of a drug or prodrug, as well as its therapeutic or prophylactic efficacy and/or adverse effects. Use of the isotope-enriched amide-containing drugs and prodrugs for the treatment or prevention of disease states and conditions is also provided.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: April 30, 2024
    Assignees: RISEN (SUZHOU) PHARMA TECH CO., LTD., SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
    Inventors: Jiasheng Lu, Jiamin Gu, Xiang Ji, Dongqing Zhu, Xiaolin He, Xianqi Kong
  • Publication number: 20240131001
    Abstract: The present application relates to a kind of fused ring phenolic compound, or a pharmaceutically acceptable salt or ester thereof, in the manufacture of medicaments for treating, inhibiting or preventing bacterial infections. The disclosed fused ring phenolic compounds can inhibit PPK1 and PPK2 and can be used to treat infections or conditions caused by bacteria such as Pseudomonas aeruginosa.
    Type: Application
    Filed: December 9, 2021
    Publication date: April 25, 2024
    Inventor: Xiang JI
  • Publication number: 20240116952
    Abstract: The disclosure relates to KRASG12D inhibitor compounds having the structure of Formula (A) or Formula (B), pharmaceutical compositions thereof, and methods of use thereof for inhibiting, treating, and/or preventing KRASG12D mutation-associated diseases, disorders and conditions.
    Type: Application
    Filed: September 8, 2023
    Publication date: April 11, 2024
    Inventors: Jiasheng LU, Xiang JI, Xianchao DU, Yanpeng WU, Xiaolin HE, Guangwei REN, Lina CHU, Chuanhao HUANG, Xingwu ZHU, Yuhua ZHANG, Jian GE, Tianlun ZHOU, Xiangsheng YE, Xianqi KONG, Dawei CHEN
  • Publication number: 20240107509
    Abstract: A resource scheduling method and a communication apparatus. In the method, a terminal device receives first indication information for determining a quantity of layers to be scheduled corresponding to each frequency domain unit in a plurality of frequency domain units, or for determining a quantity of layers to be scheduled corresponding to each frequency domain unit group in one or more frequency domain unit groups, where one frequency domain unit group includes one or more frequency domain units, one frequency domain unit includes one or more frequency domain resources with a same quantity of layers to be scheduled; and determines, based on the first indication information, a quantity of layers to be scheduled that are on frequency domain resources for data transmission, where at least two of the frequency domain resources for data transmission have different quantities of layers to be scheduled.
    Type: Application
    Filed: November 15, 2023
    Publication date: March 28, 2024
    Applicant: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Haicun HANG, Xiaohan WANG, Liuliu JI, Huangping JIN, Xiang REN
  • Publication number: 20240105499
    Abstract: Embodiments of the present technology relate to semiconductor processing methods that include providing a structured semiconductor substrate including a trench having a bottom surface and top surfaces. The methods further include depositing a portion of a silicon-containing material on the bottom surface of the trench for at least one deposition cycle, where each deposition cycle includes: depositing the portion of the silicon-containing material on the bottom surface and top surfaces of the trench, depositing a carbon-containing mask layer on the silicon-containing material on the bottom surface of the trench, where the carbon-containing mask layer is not formed on the top surfaces of the trench, removing the portion of the silicon-containing material from the top surfaces of the trench, and removing the carbon-containing mask layer from the silicon-containing material on the bottom surface of the trench, where the as-deposited silicon-containing material remains on the bottom surface of the trench.
    Type: Application
    Filed: September 28, 2022
    Publication date: March 28, 2024
    Applicant: Applied Materials, Inc.
    Inventors: Zeqing Shen, Susmit Singha Roy, Abhijit Basu Mallick, Xinke Wang, Xiang Ji, Praket Prakash Jha
  • Publication number: 20240059712
    Abstract: The disclosure relates to bifunctional KRAS-G12D-modulating compounds having the structure W-L-T, where W is a targeting group that binds specifically to KRAS-G12D protein, T is an E3-ligase binding group, and L is absent or is a bivalent linking group that connects W and T together via a covalent linkage. Compounds and pharmaceutical compositions thereof can promote degradation of the KRAS-G12D protein in a cell and are thus useful for treating, inhibiting, and preventing KRAS-G12D-associated diseases, disorders and conditions, including cancers.
    Type: Application
    Filed: September 13, 2023
    Publication date: February 22, 2024
    Inventors: Jiasheng LV, Xiang JI, Gang WU, Bin ZONG, Qiguo ZHANG, Yanpeng WU, Xiangyang LI, Yuhui CHEN, Yongyue CHEN, Chuanhao HUANG, Xingwu ZHU, Xiaolin HE, Yao LIU, Yuhua ZHANG, Jian GE, Tianlun ZHOU, Xiangsheng YE, Xianqi KONG, Dawei CHEN
  • Publication number: 20240051982
    Abstract: There are provided compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for the prevention or treatment in a manual of joint and bone disorders such as arthritis and osteoporosis.
    Type: Application
    Filed: June 20, 2023
    Publication date: February 15, 2024
    Inventors: Xianqi KONG, Jiasheng LU, Jiamin GU, Xiang JI, Daiqiang HU, Xiuchun ZHANG, Xinyong LV, Jinchao AI, Dongdong WU, Lin WANG, Dongqing ZHU, Xiaolin HE
  • Patent number: 11884423
    Abstract: Disclosed is a method for task planning of a space information network based on resource interchange. The method includes: initializing basic parameters of the space information network; dividing a planning horizon into K time slots of equal length, and constructing a resource time-varying graph for the space information network; sampling a feasible resource combination space of each task, and obtaining a candidate resource combination set comprised of the resource combinations with independence greater than or equal to a threshold n; calculating a conflict relation between resource combinations, and constructing a resource combination conflict graph; obtaining a maximum independent set of the resource combination conflict graph to obtain a global planning result; and searching a neighborhood of the global planning result, and completing a local adjustment of a task planning scheme through the resource interchange, to complete the task planning based on characteristics of the resource interchange.
    Type: Grant
    Filed: September 30, 2021
    Date of Patent: January 30, 2024
    Assignee: Xi'an University of Architecture and Technology
    Inventors: Runzi Liu, Xiang Ji, Wenzhu Zhang
  • Publication number: 20240000761
    Abstract: There are provided isotope-enriched compounds containing stable heavy isotope-enriched amide functional groups for modulating the pharmacokinetic profile, metabolic profile, and/or delivery efficiency of a drug or prodrug, as well as its therapeutic or prophylactic efficacy and/or adverse effects. Use of the isotope-enriched amide-containing drugs and prodrugs for the treatment or prevention of disease states and conditions is also provided.
    Type: Application
    Filed: March 25, 2021
    Publication date: January 4, 2024
    Inventors: Jiasheng LU, Jiamin GU, Xiang JI, Dongqing ZHU, Xiaolin HE, Xianqi KONG
  • Publication number: 20230367785
    Abstract: The disclosed systems and methods are directed towards: i) receiving at least one Yet Another Next Generation (YANG) data model, ii) converting the at least one YANG data model into a corresponding Forest Data Store (FDS) binary format, wherein the FDS binary format is divided into four areas: forest data area, meta-data area, string area, and dynamic area, and iii) transmitting the FDS binary format to at least one of: a server-network device and a client device/network management system. The systems and methods are also directed towards: i) receiving a request for configuration of the server-network device, and ii) processing the request based on the FDS binary format corresponding to at least one YANG data model.
    Type: Application
    Filed: May 10, 2022
    Publication date: November 16, 2023
    Inventors: Jian LI, Xiang JI, Danni SHANG, Cong Lin FAN
  • Publication number: 20230367748
    Abstract: The disclosed systems and methods for extracting a subtree structure from a YANG schema, the YANG schema comprising one or more YANG models, being a ramified hierarchical structure defining a plurality of nodes and relationships among the plurality of nodes and being representable under the form of a tree structure. The method comprises receiving the YANG schema and a set of extraction instructions, the extraction instructions comprising indication of one or more first nodes to be extracted from the YANG model. The one or more first nodes are further added to a set of nodes to be extracted. The method comprises executing an iterative identification process to update the set of nodes to be extracted, and further generating a trimmed YANG model based on the set of nodes to be extracted.
    Type: Application
    Filed: May 10, 2022
    Publication date: November 16, 2023
    Inventors: Jian LI, Xiang JI, Danni SHANG
  • Publication number: 20230321253
    Abstract: The disclosure relates to bifunctional KRAS-G12D-modulating compounds having the structure W-L-T, where W is a targeting group that binds specifically to KRAS-G12D protein, T is an E3-ligase binding group, and L is absent or is a bivalent linking group that connects W and T together via a covalent linkage. Compounds and pharmaceutical compositions thereof can promote degradation of the KRAS-G12D protein in a cell and are thus useful for treating, inhibiting, and preventing KRAS-G12D-associated diseases, disorders and conditions, including cancers.
    Type: Application
    Filed: March 9, 2023
    Publication date: October 12, 2023
    Inventors: Jiasheng LV, Xiangyang LI, Xiang JI, Yuhui CHEN, Yongyue CHEN, Chuanhao HUANG, Xingwu ZHU, Xiaolin HE, Jian GE, Tianlun ZHOU, Xianqi KONG, Dawei CHEN, Xiangsheng YE
  • Publication number: 20230311664
    Abstract: A vehicle and an insulation monitoring circuit for vehicle battery, the insulation monitoring circuit acquiring power from the vehicle battery and comprising a voltage-to-frequency conversion circuit (11), an RC series circuit (12), a first peak sampling circuit (13), and an alarm trigger module (14); the voltage-to-frequency conversion circuit (11) outputs a low-frequency pulse signal and injects same via the RC series circuit (12) into a high-voltage system connected to the vehicle battery; the first peak sampling circuit (13) performs sampling on a voltage signal of a resistor rear end in the RC series circuit (12) and feeds back same to the voltage-to-frequency conversion circuit (11), such that the outputted low-frequency pulse signal is adapted to the vehicle battery; and the alarm trigger module (14) performs processing on the voltage signal of the resistor rear end in the RC series circuit (12) and outputs an alarm trigger signal.
    Type: Application
    Filed: September 7, 2020
    Publication date: October 5, 2023
    Inventors: Kewei LU, Ji LI, Wendi CHEN, Huake ZHENG, Xiang JI
  • Publication number: 20230295079
    Abstract: There are provided isotope-enriched compounds of Formula (I) and pharmaceutically acceptable salts or esters thereof, as well as pharmaceutical compositions thereof and methods of use thereof for prevention and treatment of amyloid-? related diseases, such as Alzheimer's disease.
    Type: Application
    Filed: November 23, 2022
    Publication date: September 21, 2023
    Inventors: Jiasheng LU, Jiamin GU, Xinyong LV, Guowei SONG, Dongdong WU, Daiqiang HU, Jun GU, Gang CHEN, Xiang JI, Xiuchun ZHANG, Jinchao AI, Xianqi KONG
  • Patent number: 11757759
    Abstract: Systems and methods include receiving a traceroute packet at a relay node; responding to the traceroute packet with a first data structure inside the traceroute packet that indicates a propagation mode at the node and an operation type performed at the node, receiving subsequent traceroute packets from the initiator node with a second data structure inside the subsequent traceroute packets with data used to indicate changes in a header of the subsequent traceroute packets, and forwarding the subsequent traceroute packets with the changes to the header based on the data. The systems and methods can include utilizing the first data structure to determine the changes in the header of the subsequent traceroute packets. This can be used in Multiprotocol Label Switching (MPLS), Segment Routing (SR), and Internet Protocol (IP), where a TTL/Hop Limit propagation is limited.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: September 12, 2023
    Assignee: Ciena Corporation
    Inventor: Xiang Ji
  • Publication number: 20230270727
    Abstract: A VEGF inhibitor is used in preparation of a medicament for treating hypoxia-related diseases. The VEGF inhibitor can significantly inhibit VEGF stress expression caused by hypoxia by acting on a binding pathway of VEGF and a VEGF receptor, is used for treating hypoxia and other related diseases, can significantly improve the oxygenation index of a patient, and can alleviate the hypoxic state of lung and other organ tissues, having good therapeutic effects.
    Type: Application
    Filed: April 23, 2021
    Publication date: August 31, 2023
    Inventors: Yuguo CHEN, Yihai CAO, Jiaojiao PANG, Feng XU, Ming LV, Bailu WANG, Yu LI, Yuan BIAN, Xiang JI, Yuan ZHANG, Wenhai SUI
  • Publication number: 20230269222
    Abstract: A media access control (MAC) address allocation method and device are disclosed. The method includes: a wireless access point device sending a notification message on a wireless medium. The notification message includes at least one candidate virtual MAC address. The wireless access point device receiving, on the wireless medium, a request message from a terminal device. A source address of the request message is a first virtual MAC address. The first virtual MAC address is one of the at least one candidate virtual MAC address.
    Type: Application
    Filed: April 21, 2023
    Publication date: August 24, 2023
    Applicant: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Di Wu, Yijiong Zhang, Zhicheng Yang, Bin Cao, Xiang Ji, Chenhe Ji
  • Patent number: 11718636
    Abstract: There are provided compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for the prevention or treatment in a mammal of joint and bone disorders such as arthritis and osteoporosis.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: August 8, 2023
    Assignee: RISEN (SUZHOU) PHARMA TECH CO., LTD.
    Inventors: Xianqi Kong, Jiasheng Lu, Jiamin Gu, Xiang Ji, Daiqiang Hu, Xiuchun Zhang, Xinyong Lv, Jinchao Ai, Dongdong Wu, Lin Wang, Dongqing Zhu, Xiaolin He
  • Publication number: 20230227488
    Abstract: There are provided compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for the prevention or treatment in a mammal of joint and bone disorders such as arthritis and osteoporosis.
    Type: Application
    Filed: January 18, 2023
    Publication date: July 20, 2023
    Inventors: Jiasheng LU, Jiamin GU, Xiang JI, Daiqiang HU, Xiuchun ZHANG, Xinyong LV, Jinchao AI, Dongdong WU, Xianqi KONG, LIN WANG, Dongqing ZHU, Xiaolin HE